M. Tarakçıoğlu, M. Boysan, Yasin Caliskan, Ö. Demirel, N. C. Memik, M. Kadak
{"title":"Psychometric properties of the Turkish version of the Thought-Action Fusion-Child Version (TAFIC)","authors":"M. Tarakçıoğlu, M. Boysan, Yasin Caliskan, Ö. Demirel, N. C. Memik, M. Kadak","doi":"10.5455/pcp.20200212074140","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: The concept of thought-action fusion has long been recognized as a cognitive vulnerability factor for psyhopathology that given its clinical relevance and importance reliable assessment of this phenomenon seems to be essential. The aim of this study was to investigate the psychometric properties of the Thought-Action Fusion Inventory for Children (TAFIC) among Turkish children and adolescents. METHODS: Five hundred and ninety-one subjects (mean age=14.16±2.08 years) participated in the study. Voluntered subjects completed the TAFIC, Magical Ideation Scale (MIS), Child Depression Inventory (CDI), Screen for Child Anxiety Related Emotional Disorders RevisedChild Self-Report (SCARED-R-CV), and Metacognitions Questionnaire for Children (MCQ-C). RESULTS: Confirmatory factor analysis revealed the original four-factor structure excellently fit the data on the Turkish version of the TAFIC. Internal reliability of the instrument was acceptable to excellent, with Kuder-Richardson coefficients ranging from 0.70 to 0.89. The convergent validity of the TAFIC was adequate, with significant correlation coefficients with magical ideation, meta-cognitions, depression, and anxiety related emotional problems. CONCLUSIONS: Based on these findings, we concluded that the Turkish version of the TAFIC has promising psychometric properties in assessing thought-action fusion among children and adolescents.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"142 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5455/pcp.20200212074140","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE: The concept of thought-action fusion has long been recognized as a cognitive vulnerability factor for psyhopathology that given its clinical relevance and importance reliable assessment of this phenomenon seems to be essential. The aim of this study was to investigate the psychometric properties of the Thought-Action Fusion Inventory for Children (TAFIC) among Turkish children and adolescents. METHODS: Five hundred and ninety-one subjects (mean age=14.16±2.08 years) participated in the study. Voluntered subjects completed the TAFIC, Magical Ideation Scale (MIS), Child Depression Inventory (CDI), Screen for Child Anxiety Related Emotional Disorders RevisedChild Self-Report (SCARED-R-CV), and Metacognitions Questionnaire for Children (MCQ-C). RESULTS: Confirmatory factor analysis revealed the original four-factor structure excellently fit the data on the Turkish version of the TAFIC. Internal reliability of the instrument was acceptable to excellent, with Kuder-Richardson coefficients ranging from 0.70 to 0.89. The convergent validity of the TAFIC was adequate, with significant correlation coefficients with magical ideation, meta-cognitions, depression, and anxiety related emotional problems. CONCLUSIONS: Based on these findings, we concluded that the Turkish version of the TAFIC has promising psychometric properties in assessing thought-action fusion among children and adolescents.
期刊介绍:
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.